0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

Impact of Environmental Microplastics on Pregnancy and Neonatal Outcomes: A Scoping Review

Current Obstetrics and Gynecology Reports 2026
Mrinmoyee Kalasikam, Madeeha Malik, Cassidy Pham, Anna Joy Rogers

Summary

Tiny plastic particles called microplastics have been found in placentas, amniotic fluid, and other tissues involved in pregnancy, and this review of 53 studies found early evidence linking them to changes in fetal growth, birth weight, and gene activity in animal and lab studies. While these findings are concerning, most of the research so far is in animals or cells rather than humans, so scientists still need to confirm whether microplastic exposure actually causes problems for pregnant people and their babies.

Abstract Purpose of Review Microplastic pollution is a growing environmental concern with an unknown impact on health, particularly as it relates to maternal, neonatal and offspring development. This scoping review maps the available evidence on the effects of microplastics on pregnancy, neonatal, offspring and tissue outcomes. Recent Findings Microplastics (MPs) and nanoplastics (NPs) have been identified in various human tissues, from amniotic fluid to uterine and placental tissue. Emerging evidence shows that MPs and NPs can cause inflammatory changes and dysfunction in multiple organs, including the intestines, liver, and gonads. Summary A total of 806 studies were identified and imported for screening, of which 348 were eliminated after deduplication. Out of 458 abstracts, 122 abstracts moved forward into full-text review. Following the application of exclusion criteria, 53 studies underwent extraction. These studies were extracted for the following outcomes: pregnancy (5), placental (13), embryogenesis (5), fetal tissue (19), offspring (14) and neonatal outcomes (9). Broadly, the most common outcomes included changes in fetal development and birth weight, disturbances in metabolism and signaling pathways, and differences in gene expression in MP-NP exposed groups compared to control groups. Further research amongst human participants should be conducted to determine if MP-NP exposure has significant clinical effects on pregnancy and fetal outcomes.

Share this paper